LIPID-POLYMER HYBRID NANOCARRIERS AS A NOVEL DRUG DELIVERY PLATFORM
DOI:
https://doi.org/10.22159/ijpps.2022v14i4.44038Keywords:
Diagnostic, Hydrophobic, Lipophilic, Biomimetic, Biocompatibility, BiodegradableAbstract
The main aim of my review to discuss the most prominent nanocarrier, “Lipid-Polymer Hybrid Nanoparticle” (LPHNPs) that overcomes the limitation of lipid and polymeric nanoparticles. That consists of polymeric core and lipid outer layer. The polymeric core encapsulates both hydrophilic and hydrophobic drugs and lipid shell provides a coat that gives a barrier to prevent drug leakage and easily penetrate into the skin. The LPHNPs has significant application in drug delivery, drug targeting, cancer treatment, brain drug delivery, multiple drug delivery, delivery of diagnostic imaging agent and Small interfering Ribonucleic acid (siRNA).
This session is based on literature information in which LPHNPs were prepared by Two-step and Single-step method. Most of the researcher use the Single-step method by emulsification solvent evaporation and Nanoprecipitation method that are easy to prepare LPHNPs. The Polylactic Glycolic acid (PLGA), Poly € caprolactone, Chitosan, Alginate, Dextron, Sodium Alginate, etc used as polymeric core and Stearic Acid, Palmitic Acid, Cetyl Alcohol, Behenol Alcohol, etc used as lipid core. All results were analyzed by us according to the literature and authors’ expertise. The drug release depends on diffusion processes, followed by erosion, then swelling of the matrix. The lipid shell provides a biocompatible shield that acts as the phospholipid bilayer of skin and easily penetrates into the skin. That also capable to deliver the multidrug and diagnostic imaging agent for the treatment of cancer.
The Lipid-Polymer Hybrid Nanoparticles are the most prominent nanocarrier for drug delivery. That is capable to deliver both Hydrophilic and Lipophilic drugs and show high bioavailability.
Downloads
References
Fang RH, Aryal S, Hu CMJ, Zhang L. Quick synthesis of lipid-polymer hybrid nanoparticles with low polydispersity using a single-step sonication method. Langmuir. 2010;26(22):16958-62. doi: 10.1021/la103576a, PMID 20961057.
Lian T, Ho RJY. Trends and developments in liposome drug delivery systems. J Pharm Sci. 2001;90(6):667-80. doi: 10.1002/jps.1023.
Panyam J, Labhasetwar V. Biodegradable nanoparticles for drug and gene delivery to cells and tissue. Adv Drug Deliv Rev. 2003;55(3):329-47. doi: 10.1016/s0169-409x(02)00228-4, PMID 12628320.
Sharma A. Liposomes in drug delivery: progress and limitations. Int J Pharm. 1997;154(2):123-40. doi: 10.1016/S0378-5173(97)00135-X.
Mandal B, Bhattacharjee H, Mittal N, Sah H, Balabathula P, Thoma LA, Wood GC. Core–shell-type lipid-polymer hybrid nanoparticles as a drug delivery platform. Nanomedicine. 2013;9(4):474-91. doi: 10.1016/j.nano.2012.11.010. PMID 23261500.
Gessner A, Olbrich C, Schroder W, Kayser O, Muller RH. The role of plasma proteins in brain targeting: species-dependent protein adsorption patterns on brain-specific lipid drug conjugate (LDC) nanoparticles. Int J Pharm. 2001;214(1-2):87-91. doi: 10.1016/S0378-5173(00)00639-6, PMID 11282243.
Hu FQ, Jiang SP, Du YZ, Yuan H, Ye YQ, Zeng S. Preparation and characteristics of monostearin nanostructured lipid carriers. Int J Pharm. 2006;314(1):83-9. doi: 10.1016/ j.ijpharm.2006.01.040, PMID 16563671.
Gregoriadis G. Engineering liposomes for drug delivery: progress and problems. Trends Biotechnol. 1995;13(12):527-37. doi: 10.1016/S0167-7799(00)89017-4, PMID 8595139.
Lee SM, Chen H, Dettmer CM, O’Halloran TV, Nguyen ST. Polymer-caged lipsomes: a pH-responsive delivery system with high stability. J Am Chem Soc. 2007;129(49):15096-7. doi: 10.1021/ja070748i, PMID 17999499.
Pinto Reis C, Neufeld RJ, Ribeiro AJ, Veiga F, Nanoencapsulation I. Methods for preparation of drug-loaded polymeric nanoparticles. Nanomedicine: Nanotechnology Biology and Medicine. 2006;2(1):8-21. doi: 10.1016/j.nano.2005.12.003.
Allemann E, Gurny R, Doelker E. Drug-loaded nanoparticles-preparation methods and drug targeting issues. Eur J Pharm Biopharm. 1993;39(5):173-91.
Wu XY. Strategies for optimizing polymer-lipid hybrid nanoparticle-mediated drug delivery. Expert Opin Drug Deliv. 2016;13(5):609-12. doi: 10.1517/17425247.2016.1165662, PMID 26978527.
Jaiswal PK, Das S, Das MK. Boosting the skin delivery of curcumin through stearic acid-ethyl cellulose blend hybrid nanocarriers-based approach for mitigating psoriasis. Int J App Pharm. 2021;13(3):150-64. doi: 10.22159/ijap.2021v13i3.40668.
Muller RH, Mader K, Gohla S. Solid lipid nanoparticles (SLN) for controlled drug delivery- a review of the state of the art. Eur J Pharm Biopharm. 2000;50(1):161-77. doi: 10.1016/S0939-6411(00)00087-4, PMID 10840199.
Ma P, Li T, Xing H, Wang S, Sun Y, Sheng X, Wang K. Local anesthetic effects of bupivacaine loaded lipid-polymer hybrid nanoparticles: in vitro and in vivo evaluation. Biomed Pharmacother. 2017;89:689-95. doi: 10.1016/j.biopha.2017.01.175, PMID 28267672.
Devrim B, Kara A, Vural İ, Bozkır A. Lysozyme-loaded lipid-polymer hybrid nanoparticles: preparation, characterization and colloidal stability evaluation. Drug Dev Ind Pharm. 2016;42(11):1865-76. doi: 10.1080/03639045.2016.1180392, PMID 27091346.
Bose RJC, Ravikumar R, Karuppagounder V, Bennet D, Rangasamy S, Thandavarayan RA. Lipid-polymer hybrid nanoparticle-mediated therapeutics delivery: advances and challenges. Drug Discov Today. 2017;22(8):1258-65. doi: 10.1016/j.drudis.2017.05.015, PMID 28600191.
Shah J, Patel S, Bhairy S, Hirlekar R. Formulation optimization, characterization and in vitro anti-cancer activity of curcumin loaded nanostructured lipid carriers. Int J Curr Pharm Sci. 2022;14(1):31-43, doi: 10.22159/ijcpr.2022v14i1.44110.
Asuman Bozkır BD. Preparation and characterization of protein-loaded lipid-polymer hybrid nanoparticles with polycaprolactone as polymeric core material. JBiomol Res Ther. 2014;03(3):3-6. doi: 10.4172/2167-7956.1000115.
Wang J, Zhang L, Chi H, Wang S. An alternative choice of lidocaine-loaded liposomes: lidocaine-loaded lipid-polymer hybrid nanoparticles for local anesthetic therapy. Drug Deliv. 2016;23(4):1254-60. doi: 10.3109/10717544.2016.1141259, PMID 26881926.
Joshy KS, George A, Jose J, Kalarikkal N, Pothen LA, Thomas S. Novel dendritic structure of alginate hybrid nanoparticles for effective anti-viral drug delivery. Int J Biol Macromol. 2017;103:1265-75. doi: 10.1016/j.ijbiomac.2017.05.094, PMID 28559185.
Pardeshi C, Rajput P, Belgamwar V, Tekade A, Patil G, Chaudhary K, Sonje A. Solid lipid-based nanocarriers: an overview. Acta Pharm. 2012;62(4):433-72. doi: 10.2478/v10007-012-0040-z, PMID 23333884.
Chan JM, Zhang L, Yuet KP, Liao G, Rhee JW, Langer R, Farokhzad OC. PLGA-lecithin-PEG core-shell nanoparticles for controlled drug delivery. Biomaterials. 2009;30(8):1627-34. doi: 10.1016/j.biomaterials.2008.12.013, PMID 19111339.
Kanthamneni N, Chaudhary A, Wang J, Prabhu S. Nanoparticulate delivery of novel drug combination regimens for the chemoprevention of colon cancer. Int J Oncol. 2010;37(1):177-85. doi: 10.3892/ijo_00000665, PMID 20514409.
Cheow WS, Hadinoto K. Factors affecting drug encapsulation and stability of lipid-polymer hybrid nanoparticles. Colloids Surf B Biointerfaces. 2011;85(2):214-20. doi: 10.1016/j.colsurfb.2011.02.033, PMID 21439797.
Sengupta S, Eavarone D, Capila I, Zhao G, Watson N, Kiziltepe T, Sasisekharan R. Temporal targeting of tumour cells and neovasculature with a nanoscale delivery system. Nature. 2005;436(7050):568-72. doi: 10.1038/nature03794, PMID 16049491.
Zhao P, Wang H, Yu M, Liao Z, Wang X, Zhang F, Ji W, Wu B, Han J, Zhang H, Wang H, Chang J, Niu R. Paclitaxel loaded folic acid targeted nanoparticles of mixed lipid-shell and polymer-core: in vitro and in vivo evaluation. Eur J Pharm Biopharm. 2012;81(2):248-56. doi: 10.1016/j.ejpb.2012.03.004. PMID 22446630.
Bathfield M, Daviot D, D’Agosto F, Spitz R, Ladaviere C, Charreyre M, Delair T. Synthesis of lipid-α-end-functionalized chains by RAFT polymerization. Stabilization of lipid/polymer particle assemblies. Macromolecules. 2008;41(22):8346-53. doi: 10.1021/ma801567c.
Hadinoto K, Sundaresan A, Cheow WS. Lipid-polymer hybrid nanoparticles as a new generation therapeutic delivery platform: a review. Eur J Pharm Biopharm. 2013;85(3 Pt A):427-43. doi: 10.1016/j.ejpb.2013.07.002. PMID 23872180.
Mieszawska AJ, Gianella A, Cormode DP, Zhao Y, Meijerink A, Langer R, Farokhzad OC, Fayad ZA, Mulder WJ. Engineering of lipid-coated PLGA nanoparticles with a tunable payload of diagnostically active nanocrystals for medical imaging. Chem Commun (Camb). 2012;48(47):5835-7. doi: 10.1039/c2cc32149a, PMID 22555311.
Thevenot J, Troutier AL, David L, Delair T, Ladaviere C. Steric stabilization of lipid/polymer particle assemblies by poly(ethylene glycol)-lipids. Biomacromolecules. 2007;8(11):3651-60. doi: 10.1021/bm700753q, PMID 17958441.
Wang H, Zhao P, Su W, Wang S, Liao Z, Niu R, Chang J. PLGA/polymeric liposome for targeted drug and gene co-delivery. Biomaterials. 2010;31(33):8741-8. doi: 10.1016/j.biomaterials.2010.07.082, PMID 20727587.
Messerschmidt SKE, Musyanovych A, Altvater M, Scheurich P, Pfizenmaier K, Landfester K, Kontermann RE. Targeted lipid-coated nanoparticles: delivery of tumor necrosis factor-functionalized particles to tumor cells. J Control Release. 2009;137(1):69-77. doi: 10.1016/j.jconrel.2009.03.010, PMID 19306900.
Hitzman CJ, Elmquist WF, Wiedmann TS. Development of a respirable, sustained release microcarrier for 5-fluorouracil II: in vitro and in vivo optimization of lipid coated nanoparticles. J Pharm Sci. 2006;95(5):1127-43. doi: 10.1002/jps.20590, PMID 16570303.
Li X, Anton N, Arpagaus C, Belleteix F, Vandamme TF. Nanoparticles by spray drying using innovative new technology: the Buchi Nano Spray Dryer B-90. J Control Release. 2010;147(2):304-10. doi: 10.1016/j.jconrel.2010.07.113, PMID 20659510.
Hasan W, Chu K, Gullapalli A, Dunn SS, Enlow EM, Luft JC, Tian S, Napier ME, Pohlhaus PD, Rolland JP, DeSimone JM. Delivery of multiple siRNAs using lipid-coated PLGA nanoparticles for treatment of prostate cancer. Nano Lett. 2012;12(1):287-92. doi: 10.1021/nl2035354, PMID 22165988.
Troutier AL, Delair T, Pichot C, Ladavière C. Physicochemical and interfacial investigation of lipid/polymer particle assemblies. Langmuir. 2005;21(4):1305-13. doi: 10.1021/la047659t, PMID 15697275.
Zhang L, Chan JM, Gu FX, Rhee JW, Wang AZ, Radovic Moreno AF, Alexis F, Langer R, Farokhzad OC. Self-assembled lipid--polymer hybrid nanoparticles: a robust drug delivery platform. ACS Nano. 2008;2(8):1696-702. doi: 10.1021/nn800275r, PMID 19206374.
JC Bose R, Lee S, Park H. Lipid polymer hybrid nanospheres encapsulating antiproliferative agents for stent applications. J Ind Eng Chem. 2016;36:284-92. doi: 10.1016/j.jiec.2016.02.015.
Mandal B, Bhattacharjee H, Mittal N, Sah H, Balabathula P, Thoma LA, Wood GC. Core-shell-type lipid-polymer hybrid nanoparticles as a drug delivery platform. Nanomedicine. 2013;9(4):474-91. doi: 10.1016/j.nano.2012.11.010. PMID 23261500.
Li Q, Cai T, Huang Y, Xia X, Cole SPC, Cai Y. A review of the structure, preparation, and application of NLCs, PNPs, and PLNs. Nanomaterials (Basel). 2017;7(6):122. doi: 10.3390/nano7060122, PMID 28554993.
Valencia PM, Basto PA, Zhang L, Rhee M, Langer R, Farokhzad OC, Karnik R. Single-step assembly of homogenous lipid-polymeric and lipid-quantum dot nanoparticles enabled by rapid microfluidic mixing. ACS Nano. 2010;4(3):1671-9. doi: 10.1021/nn901433u, PMID 20166699.
Panagiotou T, Mesite SV, Fisher RJ. Production of norfloxacin nanosuspensions using microfluidics reaction technology through solvent/antisolvent crystallization. Ind Eng Chem Res. 2009;48(4):1761-71. doi: 10.1021/ie800955t.
De Geest BG, De Koker S, Demeester J, De Smedt SC, Hennink WE. Pulsed in vitro release and in vivo behavior of exploding microcapsules. J Control Release. 2009;135(3):268-73. doi: 10.1016/j.jconrel.2009.01.017, PMID 19331854.
Liu Y, Li K, Pan J, Liu B, Feng SS. Folic acid conjugated nanoparticles of mixed lipid monolayer shell and biodegradable polymer core for targeted delivery of Docetaxel. Biomaterials. 2010;31(2):330-8. doi: 10.1016/j.biomaterials.2009.09.036, PMID 19783040.
Aubry J, Ganachaud F, Cohen Addad JPC, Cabane B. Nanoprecipitation of polymethylmethacrylate by solvent shifting: 1. Boundaries. Langmuir. 2009;25(4):1970-9. doi: 10.1021/la803000e, PMID 19170510.
Amrutha U, Sushmitha B, Rubina S, Iriventi P. Formulation and evaluation of solid lipid nanoparticles containing caffeine to treat clinical mastitis. Asian J Pharm Clin Res. 2020;13(7):72-8. doi: 10.22159/ajpcr.2020.v13i7.37642.
Palange AL, Di Mascolo D, Carallo C, Gnasso A, Decuzzi P. Lipid-polymer nanoparticles encapsulating curcumin for modulating the vascular deposition of breast cancer cells. Nanomedicine. 2014;10(5):991-1002. doi: 10.1016/j.nano.2014.02.004. PMID 24566270.
Bershteyn A, Chaparro J, Yau R, Kim M, Reinherz E, Ferreira-Moita L, Irvine DJ. Polymer-supported lipid shells, onions, and flowers. Soft Matter. 2008;4(9):1787-91. doi: 10.1039/b804933e, PMID 19756178.
Chapter BS 2. Nanoparticles types, classification, characterization, fabrication methods, and drug delivery applications; 2016. doi: 10.1007/978-3-319-41129-3.
Pradhan M, Singh D, Singh MR. Novel colloidal carriers for psoriasis: current issues, mechanistic insight and novel delivery approaches. J Control Release. 2013;170(3):380-95. doi: 10.1016/j.jconrel.2013.05.020, PMID 23770117.
Jain S, Jain V, Mahajan SC. Lipid-based vesicular drug delivery systems. Advances in Pharmaceutics. 2014;2014:1-12. doi: 10.1155/2014/574673.
Rawat M, Singh D, Saraf S, Saraf S. Nanocarriers: promising vehicle for bioactive drugs. Biol Pharm Bull. 2006;29(9):1790-8. doi: 10.1248/bpb.29.1790, PMID 16946487.
Verma DD, Verma S, Blume G, Fahr A. Particle size of liposomes influences dermal delivery of substances into skin. Int J Pharm. 2003;258(1-2):141-51. doi: 10.1016/S0378-5173(03)00183-2, PMID 12753761.
Mezei M, Gulasekharam V. Liposomes-a selective drug delivery system for the topical route of administration: gel dosage form. J Pharm Pharmacol. 1982;34(7):473-4. doi: 10.1111/j.2042-7158.1982.tb04767.x. PMID 6126554.
Agarwal R, Katare OP, Vyas SP. Preparation and in vitro evaluation of liposomal/niosomal delivery systems for antipsoriatic drug dithranol. Int J Pharm. 2001;228(1-2):43-52. doi: 10.1016/s0378-5173(01)00810-9, PMID 11576767.
Manconi M, Sinico C, Valenti D, Loy G, Fadda AM. Niosomes as carriers for tretinoin. I. Preparation and properties. Int J Pharm. 2002;234(1-2):237-48. doi: 10.1016/S0378-5173(01)00971-1, PMID 11839454.
Majority R, Bodla RB, Dhamande K, Singh D, Patel L. Niosomal drug delivery system: the magic bullet. J Appl Pharm Sci. 2011;1(9):20-3.
Abhinav K, Lal PJ, Amit J, Vishwabhan S. Review on niosomes as novel drug delivery system. Int J Res Ayurveda Pharm. 2013;4(5):241-5.
Cevc G, Blume G. Lipid vesicles penetrate into intact skin owing to the transdermal osmotic gradients and hydration force. Biochimica et Biophysica Acta (BBA)- Biomembranes. 1992;1104(1):226-32. doi: 10.1016/0005-2736(92)90154-E.
Trotta M, Peira E, Carlotti ME, Gallarate M. Deformable liposomes for dermal administration of methotrexate. Int J Pharm. 2004;270(1-2):119-25. doi: 10.1016/j.ijpharm.2003.10.006. PMID 14726128.
Lee D, Weitz DA. Double emulsion-templated nanoparticle colloidosomes with selective permeability. Adv Mater. 2008;20(18):3498-503. doi: 10.1002/adma.200800918.
Jaiswal PK, Keserwani S, Keserwani R, Patel DK. Ethosome: A new technology used as topical and transdermal. J Drug Deliv Ther. 2016;6(3):7-17.
Dubey V, Mishra D, Dutta T, Nahar M, Saraf DK, Jain NK. Dermal and transdermal delivery of an anti-psoriatic agent via ethanolic liposomes. J Control Release. 2007;123(2):148-54. doi: 10.1016/j.jconrel.2007.08.005. PMID 17884226.
Manconi M, Sinico C, Caddeo C, Vila AO, Valenti D, Fadda AM. Penetration enhancer containing vesicles as carriers for dermal delivery of tretinoin. Int J Pharm. 2011;412(1-2):37-46. doi: 10.1016/j.ijpharm.2011.03.068, PMID 21530626.
Li G, Fan C, Li X, Fan Y, Wang X, Li M, Liu Y. Preparation and in vitro evaluation of tacrolimus-loaded ethosomes. Scientific World Journal. 2012;2012:874053. doi: 10.1100/2012/874053. PMID 22629219.
Singh D, Rawat Singh M, Saraf S, Dixit VK, Saraf S. Formulation optimization of metronidazole loaded chitosan microspheres for wound management by 3-factor, 3-level Box-Behnken design. MNS. 2010;2(2):70-7. doi: 10.2174/1876402911002020070.
Singh M, Prashar Y. Cerebral cortex and hippocampal protection mediated by callistemon viminalis in aluminum chloride-induced alzheimer’s disease. Indian J Pharm Educ Res. 2020;54(2):422-31. doi: 10.5530/ijper.54.2.48.
Alagusundaram M, Madhu Sudana Chetty C, Umashankari K, Badarinath AV, Lavanya C, Ramkanth S. Microspheres as a novel drug delivery system-a review. Int J Chem Technol Research. 2009;1(3);4290:526-34.
Berkland C, Kipper MJ, Narasimhan B, Kim KK, Pack DW. Microsphere size, precipitation kinetics and drug distribution control drug release from biodegradable polyanhydride microspheres. J Control Release. 2004;94(1):129-41. doi: 10.1016/j.jconrel.2003.09.011, PMID 14684277.
Ekambaram P, Abdul A, Sathali H, Priyanka K. Solid lipid nanoparticles: a review. Scientific Reviews and Chemical Communications. 2012;2(1):80-102.
Rawat M, Singh D, Saraf S, Saraf S. Lipid carriers: A versatile delivery vehicle for proteins and peptides. Yakugaku Zasshi. 2008;128(2):269-80. doi: 10.1248/yakushi.128.269, PMID 18239375.
Liechty WB, Kryscio DR, Slaughter BV, Peppas NA. Polymers for drug delivery systems. Annu Rev Chem Biomol Eng. 2010;1:149-73. doi: 10.1146/annurev-chembioeng-073009-100847. PMID 22432577.
Torchilin VP. Structure and design of polymeric surfactant-based drug delivery systems. J Control Release. 2001;73(2-3):137-72. doi: 10.1016/S0168-3659(01)00299-1, PMID 11516494.
Dhembre GN, Moon RS, Kshirsagar RV. A review on polymeric micellar nanocarriers. Int J Pharm Biol Sci. 2011;2(2):109-16.
Kesharwani S, Jaiswal PK, Kesharwani R, Kumar V, Patel DK. Dendrimer: a novel approach for drug delivery. Journal of Pharmaceutical and Scientific Innovation. 2016;5(2):54-62. doi: 10.7897/2277-4572.05212.
Chan JM, Valencia PM, Zhang L, Langer R, Farokhzad OC. Polymeric nanoparticles for drug delivery. Methods Mol Biol. 2010;624:163-75. doi: 10.1007/978-1-60761-609-2_11, PMID 20217595.
Kumari A, Yadav SK, Yadav SC. Biodegradable polymeric nanoparticles based drug delivery systems. Colloids Surf B Biointerfaces. 2010;75(1):1-18. doi: 10.1016/ j.colsurfb.2009.09.001. PMID 19782542.
Singh D, Singh MR. Development of antibiotic and debriding enzyme-loaded PLGA microspheres entrapped in PVA-gelatin hydrogel for complete wound management. Artif Cells Blood Substit Immobil Biotechnol. 2012;40(5):345-53. doi: 10.3109/10731199.2012.675337, PMID 22540900.
Amin S, Rajabnezhad S, Kohli K. Hydrogels as potential drug delivery systems. Sci Res Essays. 2009;3(11):1175-83.
Sachan NK, Bhattacharya A. Modeling and characterization of drug release from glutinous rice starch based hydrogel beads to control drug delivery. Int J Health Res. 2009;2(1):93-9.
Peppas NA, Bures P, Leobandung W, Ichikawa H. Hydrogels in pharmaceutical formulations. Eur J Pharm Biopharm. 2000;50(1):27-46. doi: 10.1016/S0939-6411(00)00090-4, PMID 10840191.
Chu CH, Wang YC, Huang HY, Wu LC, Yang CS. Ultrafine PEG-coated poly(lactic-co-glycolic acid) nanoparticles formulated by hydrophobic surfactant-assisted one-pot synthesis for biomedical applications. Nanotechnology. 2011;22(18):185601. doi: 10.1088/0957-4484/22/18/185601.
Cheow WS, Chang MW, Hadinoto K. The roles of lipid in anti-biofilm efficacy of lipid–polymer hybrid nanoparticles encapsulating antibiotics. Colloids Surf A Physicochem Eng Aspects. 2011;389(1-3):158-65. doi: 10.1016/j.colsurfa.2011.08.035.
Cheow WS, Hadinoto K. Lipid-polymer hybrid nanoparticles with rhamnolipid-triggered release capabilities as anti-biofilm drug delivery vehicles. Particuology. 2012;10(3):327-33. doi: 10.1016/j.partic.2011.08.007.
Wang Y, Kho K, Cheow WS, Hadinoto K. A comparison between spray drying and spray freeze drying for dry powder inhaler formulation of drug-loaded lipid-polymer hybrid nanoparticles. Int J Pharm. 2012;424(1-2):98-106. doi: 10.1016/j.ijpharm.2011.12.045, PMID 22226876.
Liu Y, Pan J, Feng SS. Nanoparticles of lipid monolayer shell and biodegradable polymer core for controlled release of paclitaxel: effects of surfactants on particles size, characteristics and in vitro performance. Int J Pharm. 2010;395(1-2):243-50. doi: 10.1016/j.ijpharm.2010.05.008. PMID 20472049.
Shah J, Patel S, Bhairy S, Hirlekar R. Formulation optimization, characterization and in vitro anti-cancer activity of curcumin loaded nanostructured lipid carriers. Int J Curr Pharm Sci. 2022;14(1):31-43, doi: 10.22159/ijcpr.2022v14i1.44110.
Ebos JML, Lee CR, Kerbel RS. Tumor and host-mediated pathways of resistance and disease progression in response to antiangiogenic therapy. Clin Cancer Res. 2009;15(16):5020-5. doi: 10.1158/1078-0432.CCR-09-0095. PMID 19671869.
Wang AZ, Yuet K, Zhang L, Gu FX, Huynh-Le M, Radovic-Moreno AF, Kantoff PW, Bander NH, Langer R, Farokhzad OC. ChemoRad nanoparticles: a novel multifunctional nanoparticle platform for targeted delivery of concurrent chemoradiation. Nanomedicine (Lond). 2010;5(3):361-8. doi: 10.2217/nnm.10.6, PMID 20394530.
Kong SD, Sartor M, Hu CM, Zhang W, Zhang L, Jin S. Magnetic field activated lipid-polymer hybrid nanoparticles for stimuli-responsive drug release. Acta Biomater. 2013;9(3):5447-52. doi: 10.1016/j.actbio.2012.11.006. PMID 23149252.
Aryal S, Hu CMJ, Zhang L. Polymeric nanoparticles with precise ratiometric control over drug loading for combination therapy. Mol Pharm. 2011;8(4):1401-7. doi: 10.1021/mp200243k, PMID 21696189.
Levchenko A, Mehta BM, Niu X, Kang G, Villafania L, Way D, Polycarpe D, Sadelain M, Larson SM. Intercellular transfer of P-glycoprotein mediates acquired multidrug resistance in tumor cells. Proceedings of the National Academy of Sciences of the United States of America. 2005;102(6):1933-8. doi: 10.1073/pnas.0401851102, PMID 15671173.
Aryal S, Hu CMJ, Zhang L. Combinatorial drug conjugation enables nanoparticle dual-drug delivery. Small. 2010;6(13):1442-8. doi: 10.1002/smll.201000631, PMID 20564488.
Aryal S, Jack Hu CM, Fu V, Zhang L. Nanoparticle drug delivery enhances the cytotoxicity of hydrophobic-hydrophilic drug conjugates. Journal of Materials Chemistry. 2012;22(3):994-9. doi: 10.1039/C1JM13834K.
Kularatne SA, Low PS. Targeting of nanoparticles: folate receptor. Methods in Molecular Biology. 2010;624:249-65. doi: 10.1007/978-1-60761-609-2_17, PMID 20217601.
Hu CM, Kaushal S, Tran Cao HS, Aryal S, Sartor M, Esener S, Bouvet M, Zhang L. Half-antibody functionalized lipid-polymer hybrid nanoparticles for targeted drug delivery to carcinoembryonic antigen presenting pancreatic cancer cells. Molecular Pharmaceutics. 2010;7(3):914-20. doi: 10.1021/mp900316a, PMID 20394436.
Chan JM, Rhee JW, Drum CL, Bronson RT, Golomb G, Langer R, Farokhzad OC. In vivo prevention of arterial restenosis with paclitaxel-encapsulated targeted lipid-polymeric nanoparticles. Proceedings of the National Academy of Sciences of the United States of America. 2011;108(48):19347-52. doi: 10.1073/pnas.1115945108, PMID 22087004.
Chan JM, Zhang L, Tong R, Ghosh D, Gao W, Liao G, Yuet KP, Gray D, Rhee JW, Cheng J, Golomb G, Libby P, Langer R, Farokhzad OC. Spatiotemporal controlled delivery of nanoparticles to injured vasculature. Proceedings of the National Academy of Sciences of the United States of America. 2010;107(5):2213-8. doi: 10.1073/pnas.0914585107, PMID 20133865.
Zheng Y, Yu B, Weecharangsan W, Piao L, Darby M, Mao Y, Koynova R, Yang X, Li H, Xu S, Lee LJ, Sugimoto Y, Brueggemeier RW, Lee RJ. Transferrin-conjugated lipid-coated PLGA nanoparticles for targeted delivery of aromatase inhibitor 7α-APTADD to breast cancer cells. International Journal of Pharmaceutics. 2010;390(2):234-41. doi: 10.1016/j.ijpharm.2010.02.008. PMID 20156537.
El-Aneed A. An overview of current delivery systems in cancer gene therapy. J Control Release. 2004;94(1):1-14. doi: 10.1016/j.jconrel.2003.09.013, PMID 14684267.
Bivas Benita M, Romeijn S, Junginger HE, Borchard G. PLGA-PEI nanoparticles for gene delivery to pulmonary epithelium. European Journal of Pharmaceutics and Biopharmaceutics. 2004;58(1):1-6. doi: 10.1016/j.ejpb.2004.03.008. ejpb.2004.03.008. PMID 15207531.
Lee M, Kim SW. Polyethylene glycol-conjugated copolymers for plasmid DNA delivery. Pharmaceutical Research. 2005;22(1):1-10. doi: 10.1007/s11095-004-9003-5, PMID 15771224.
Zhong Q, Chinta DM, Pamujula S, Wang H, Yao X, Mandal TK, Luftig RB. Optimization of DNA delivery by three classes of hybrid nanoparticle/DNA complexes. Journal of Nanobiotechnology. 2010;8(1):6. doi: 10.1186/1477-3155-8-6, PMID 20181278.
Li J, He YZ, Li W, Shen YZ, Li YR, Wang YF. A novel polymer-lipid hybrid nanoparticle for efficient nonviral gene delivery. Acta Pharmacologica Sinica. 2010;31(4):509-14. doi: 10.1038/aps.2010.15, PMID 20348944.
Parker AL, Newman C, Briggs S, Seymour L, Sheridan PJ. Nonviral gene delivery: techniques and implications for molecular medicine. Expert Rev Mol Med. 2003;5(22):1-15. doi: 10.1017/S1462399403006562.
Oh YK, Park TG. siRNA delivery systems for cancer treatment. Adv Drug Deliv Rev. 2009;61(10):850-62. doi: 10.1016/j.addr.2009.04.018, PMID 19422869.
Shi J, Xiao Z, Votruba AR, Vilos C, Farokhzad OC. Differentially charged hollow core/shell lipid-polymer-lipid hybrid nanoparticles for small interfering RNA delivery. Angewandte Chemie International Edition Engl. 2011;50(31):7027-31. doi: 10.1002/anie.201101554, PMID 21698724.
Li J, He YZ, Li W, Shen YZ, Li YR, Wang YF. A novel polymer-lipid hybrid nanoparticle for efficient nonviral gene delivery. Acta Pharmacol Sin. 2010;31(4):509-14. doi: 10.1038/aps.2010.15, PMID 20348944.
Su X, Fricke J, Kavanagh DG, Irvine DJ. In vitro and in vivo mRNA delivery using lipid-enveloped pH-responsive polymer nanoparticles. Molecular Pharmaceutics. 2011;8(3):774-87. doi: 10.1021/mp100390w, PMID 21417235.
Yang XZ, Dou S, Wang YC, Long HY, Xiong MH, Mao CQ, Yao YD, Wang J. Single-step assembly of cationic lipid-polymer hybrid nanoparticles for systemic delivery of siRNA. ACS Nano. 2012;6(6):4955-65. doi: 10.1021/nn300500u, PMID 22646867.
Gary DJ, Puri N, Won YY. Polymer-based siRNA delivery: perspectives on the fundamental and phenomenological distinctions from polymer-based DNA delivery. J Control Release. 2007;121(1-2):64-73. doi: 10.1016/j.jconrel.2007.05.021, PMID 17588702.
Kandel PK, Fernando LP, Ackroyd PC, Christensen KA. Incorporating functionalized polyethylene glycol lipids into reprecipitated conjugated polymer nanoparticles for bioconjugation and targeted labeling of cells. Nanoscale. 2011;3(3):1037-45. doi: 10.1039/C0NR00746C, PMID 21152603.
Published
How to Cite
Issue
Section
Copyright (c) 2022 PANKAJ KUMAR JAISWAL, SHIKHA KESERWANI, TAPASH CHAKRABARTY
This work is licensed under a Creative Commons Attribution 4.0 International License.
